Literature DB >> 16153697

Morbidity of rectosigmoid resection and primary anastomosis in patients undergoing primary cytoreductive surgery for advanced epithelial ovarian cancer.

Susannah M Mourton1, Larissa K Temple, Nadeem R Abu-Rustum, Mary L Gemignani, Yukio Sonoda, Bernard H Bochner, Richard R Barakat, Dennis S Chi.   

Abstract

OBJECTIVES: Studies from the colorectal literature have shown that factors associated with anastomotic leak after colorectal resection include long surgical time (>2 h), multiple blood transfusions, and short distance to the anal verge. The aim of this study was to assess the morbidity associated with en bloc resection of ovarian carcinoma with low anterior resection and anastomosis in patients undergoing primary cytoreductive surgery for advanced disease.
METHODS: We performed a retrospective chart review of all patients who had undergone primary cytoreduction for advanced epithelial ovarian cancer with rectosigmoid resection followed by low rectal anastomosis between January 1994 and June 2004. Patient characteristics, operative details, and postoperative complications were extracted from patients' charts.
RESULTS: Seventy patients met the above criteria and form our study group. The median age was 59 years (range, 25-82). There were 52 stage IIIC (74%) and 18 stage IV (26%) cancers. The median operating time was 315 min (range, 120-750) and the median estimated blood loss was 1200 ml (range, 250-8000), with 53 (76%) patients requiring blood transfusion. Twenty-eight patients (40%) underwent major upper abdominal procedures other than omentectomy, and 14 patients (20%) underwent a second bowel resection. Twelve patients (17%) underwent a protective ileostomy while the remainder (83%) did not. Of the 58 patients with no ostomy, the only complications associated with the resection and anastomoses were a pelvic abscess in 3 patients (5%) and an anastomotic leak requiring diverting colostomy in 1 patient (1.7%). Of the 12 patients who had protective ileostomies, 3 (25%) had complications related to their ileostomy short-bowel syndrome requiring early reversal, incarceration of the prolapsed loop requiring surgical correction, and prolapse corrected electively at the time of second-look surgery.
CONCLUSIONS: In women undergoing primary cytoreductive surgery, the morbidity associated with en bloc resection of ovarian carcinoma with low rectosigmoid resection and anastomosis without protective ileostomy was acceptably low, with an anastomotic leak rate of less than 2%. Protective ileostomy is not always necessary and should be used selectively.

Entities:  

Mesh:

Year:  2005        PMID: 16153697     DOI: 10.1016/j.ygyno.2005.07.112

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  26 in total

1.  Outcome of Bowel Resection in Women with Advanced Ovarian Carcinoma.

Authors:  Ajit Sebastian; Anitha Thomas; Gigi Varghese; Bijesh Yadav; Rachel Chandy; Abraham Peedicayil
Journal:  Indian J Surg Oncol       Date:  2018-07-20

2.  A prospective trial of acute normovolemic hemodilution in patients undergoing primary cytoreductive surgery for advanced ovarian cancer.

Authors:  Edward J Tanner; Olga T Filippova; Ginger J Gardner; Kara C Long Roche; Yukio Sonoda; Oliver Zivanovic; Mary Fischer; Dennis S Chi
Journal:  Gynecol Oncol       Date:  2018-10-16       Impact factor: 5.482

3.  Incidence of and risk factors for postoperative ileus in women undergoing primary staging and debulking for epithelial ovarian carcinoma.

Authors:  Jamie N Bakkum-Gamez; Carrie L Langstraat; Janice R Martin; Maureen A Lemens; Amy L Weaver; Sumer Allensworth; Sean C Dowdy; William A Cliby; Bobbie S Gostout; Karl C Podratz
Journal:  Gynecol Oncol       Date:  2012-02-24       Impact factor: 5.482

Review 4.  Cytoreductive Surgery and Peritonectomy Procedures.

Authors:  Sanket S Mehta; Aditi Bhatt; Olivier Glehen
Journal:  Indian J Surg Oncol       Date:  2016-02-03

5.  Development and validation of a risk-calculator for adverse perioperative outcomes for women with ovarian cancer.

Authors:  Stephanie Cham; Ling Chen; Caryn M St Clair; June Y Hou; Ana I Tergas; Alexander Melamed; Cande V Ananth; Alfred I Neugut; Dawn L Hershman; Jason D Wright
Journal:  Am J Obstet Gynecol       Date:  2019-02-13       Impact factor: 8.661

6.  Utility of closed suction pelvic drains at time of large bowel resection for ovarian cancer.

Authors:  Eleftheria Kalogera; Sean C Dowdy; Andrea Mariani; Giovanni Aletti; Jamie N Bakkum-Gamez; William A Cliby
Journal:  Gynecol Oncol       Date:  2012-05-20       Impact factor: 5.482

7.  Maximal cytoreductive effort in epithelial ovarian cancer surgery.

Authors:  Karin K Shih; Dennis S Chi
Journal:  J Gynecol Oncol       Date:  2010-06-30       Impact factor: 4.401

Review 8.  Radical surgery in ovarian cancer.

Authors:  Deepa Maheswari Narasimhulu; Fady Khoury-Collado; Dennis S Chi
Journal:  Curr Oncol Rep       Date:  2015-04       Impact factor: 5.075

9.  Clinical Significance of Mesenteric Lymph Node Involvement in the Pattern of Liver Metastasis in Patients with Ovarian Cancer.

Authors:  Kana Tanaka; Yoshifumi Shimada; Koji Nishino; Kosuke Yoshihara; Masato Nakano; Hitoshi Kameyama; Takayuki Enomoto; Toshifumi Wakai
Journal:  Ann Surg Oncol       Date:  2021-04-05       Impact factor: 5.344

10.  Diverting ileostomy during primary debulking surgery for ovarian cancer: Associated factors and postoperative outcomes.

Authors:  Jill H Tseng; Rudy S Suidan; Oliver Zivanovic; Ginger J Gardner; Yukio Sonoda; Douglas A Levine; Nadeem R Abu-Rustum; William P Tew; Dennis S Chi; Kara Long Roche
Journal:  Gynecol Oncol       Date:  2016-06-04       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.